CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating activities
Net loss	$ (3,868,074)	$ (2,425,721)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, amortization and impairment	8,466	118,941
Equity-based compensation expense	71,314	41,441
Change in fair value of warrant liability	(220,435)	0
Changes in operating assets and liabilities:
Grants receivable	(1,834,439)	0
Prepaid expenses and other current assets	617,709	(108,034)
Accounts payable	(741,018)	1,008,454
Accrued expenses and other current liabilities	298,369	(486,641)
Due to/from related party	0	1,256
Deferred revenue	(541,701)	(1,551,412)
Net cash used in operating activities	(6,184,809)	(3,401,716)
Financing activities
Proceeds from issuance of equity securities, net	9,592,325	1,508,179
Distribution to members	0	(99,758)
Proceeds from warrants exercised for cash	578,714	0
Payments on note payable	(502,332)	0
Net cash provided by financing activities	9,668,707	1,408,421
Net increase (decrease) in cash, cash equivalents and restricted cash	3,483,898	(1,993,295)
Cash, cash equivalents and restricted cash at beginning of period	3,738,900	6,131,781
Cash, cash equivalents and restricted cash at end of period	7,222,798	4,138,486
Supplemental disclosure of cash flow information:
Cash paid for interest	4,275	0
Non-cash investing and financing activities:
Accrued issuance costs for public offering	125,159	0
Issuance of shares for license	0	110,474
Conversion of liabilities to equity	0	2,869,412
Nonemployee
Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation expense	$ 25,000	$ 0